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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYAn open question remains in cancer stem cell (CSC) biology whether CSCs are by definition at the top of the differentiation hierarchy of
the tumor. Wilms’ tumor (WT), composed of blastema and differentiated renal elements resembling the nephrogenic zone of the devel-
oping kidney, is a valuable model for studying this question because early kidney differentiation is well characterized. WT neural cell
adhesion molecule 1-positive (NCAM1+) aldehyde dehydrogenase 1-positive (ALDH1+) CSCs have been recently isolated and shown
to harbor early renal progenitor traits. Herein, by generating pure blastemaWT xenografts, composed solely of cells expressing the renal
developmental markers SIX2 and NCAM1, we surprisingly show that sorted ALDH1+ WT CSCs do not correspond to earliest renal stem
cells. Rather, gene expression and proteomic comparative analyses disclose a cell type skewedmore toward epithelial differentiation than
the bulk of the blastema. Thus, WT CSCs are likely to dedifferentiate to propagate WT blastema.INTRODUCTION
The cancer stem cell (CSC) model suggests that whereas
most tumor cells are destined to differentiate, albeit aber-
rantly, a small subset of tumor cells, termed CSCs, actively
sustain and propagate the tumor. Although CSCs are
considered to be at the top of the differentiation hierarchy
of the tumor, this has not been examined in human
tumors. Wilms’ tumor (WT), a prototype of differentiation
failure in human cancer, shares the histology of the fetal
kidney, including blastema, stroma, and differentiating
tubular epithelium (Shukrun et al., 2014; Dekel et al.,
2006; Pode-Shakked and Dekel, 2011; Rivera and Haber,
2005). Because normal renal differentiation is well charac-
terized,WTrepresents an invaluablemodel for establishing
the position of CSC with respect to this differentiation
cascade.
Kidney development is initiated when the Wolffian duct
sends off a dorsal branch, the ureteric bud (UB), to invade
the metanephric mesenchyme (MM) (Pleniceanu et al.,
2010). The UB receives MM-derived signals to undergo
branching morphogenesis and develop into the collecting
system. Reciprocally, a fraction of the MM, termed cap
mesenchyme (CM), receives signals from the UB tips,
facilitating its survival, proliferation, and mesenchymal-
to-epithelial transition (MET) into nephron epithelia.24 Stem Cell Reports j Vol. 3 j 24–33 j July 8, 2014 j ª2014 The AuthorsSequential steps during renal MET have been characterized
by specific gene expression and signaling pathway activity.
This process is accompanied by gradual loss of renal devel-
opmental factors and mesenchymal markers (e.g., SIX2,
CITED1, and vimentin) and acquisition of epithelial pro-
teins (e.g., E-Cadherin) (Cirio et al., 2014; Metsuyanim
et al., 2009; Self et al., 2006). The CM has been recently
shown to consist of true stem cells, capable of self-renewing
and differentiating toward different types of nephron
epithelia (Cirio et al., 2014; Kobayashi et al., 2008).
We have recently uncovered the identity of human
WT CSCs. WT CSCs were isolated from trilineage WT
(composed of blastema, stroma, and tubular epithelium)
propagated in mice and characterized by high expression
levels of neural cell adhesion molecule 1 (NCAM1) and
aldehyde dehydrogenase 1 (ALDH1) enzymatic activity
(Pode-Shakked et al., 2013). These cells possessed both
self-renewal and multilineage differentiation capacities,
in line with the CSC definition. Immunohistochemical
(IHC) analysis of WTs revealed that the CSC population
was exclusively localized and scattered within the
NCAM1-expressing blastema (Pode-Shakked et al., 2013).
TheWT blastema, suggested to resemble the CMharboring
multipotent embryonic renal stem cells, is classically
regarded as a homogeneous unit. Thus, whereas our anal-
ysis demonstrated WT CSCs to overexpress the renal
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SALL1), compatible with early renal progenitor cells, it
was confounded by the presence of mature elements, and
the precise developmental phenotype in regard to renal
lineage differentiation remained elusive.
Therefore, to pinpoint the exact stage of the WT CSC in
respect to embryonic renal stem cell differentiation, high-
resolution analysis of a pure blastema population is
required. Here, we created an in vivo model of pure blas-
tema WT via serial propagation of human WT xenograft
(Xn). This allowed us to show that the WT blastema is a
heterogeneous-differentiating cell population that follows
the renal developmental MET axis. Within this differentia-
tion gradient of WT blastema, we show that WT CSCs are
committed epithelial progenitors, and not the earliest
mesenchymal renal stem cells, the presumable WT cell of
origin (Li et al., 2002). Hence, WT CSCs must possess
both dedifferentiation capacity forming less-differentiated,
SIX2-high blastemal cells, as well as epithelial differentia-
tion capability, as previously shown for NCAM1+ALDH1+
WT CSCs (Pode-Shakked et al., 2013). Dedifferentiation
ofWT CSCs into early mesodermal cells might also explain
the presence of heterologousmesodermal elements such as
muscle and bone seen in some WTs (Royer-Pokora et al.,
2010).RESULTS
Generation of Pure Blastema WT Xns
Previous work in our lab demonstrated that whereas WT
blastema is lost upon in vitro propagation, generation of
WT Xn preserves and even expands the blastema in vivo
(Dekel et al., 2006; Metsuyanim et al., 2009). Here, we
show that late-generation (passages 10–15) Xns are
composed solely of homogeneous-appearing sheets of
blastema cells (Figure 1A). Recently, utilizing low-passage
WT Xns (passages 1–5), which maintain most of the
primary tumor’s properties (i.e., gene expression and trili-
neage histology), we isolated CSCs that exclusively initiate
and sustain the tumor in vivo (Dekel et al., 2008). These
NCAM1+ALDH1+ WT CSCs were shown to harbor renal
stem cell characteristics compared to all other tumor
components (Pode-Shakked et al., 2013). To further
analyze late-generation Xns, we examined NCAM1 expres-
sion in comparison with primary human WT and early
WT Xns. IHC revealed NCAM1 enrichment along serial
passages of the tumor in mice (Figures 1B and 1C, left
panel). Flow cytometry analysis performed on late Xns
demonstrated that 100% of the cells express NCAM1 (Fig-
ure S1A available online). In addition, IHC showed these
pure blastemaWT Xn cells to uniformly express SIX2. (Fig-
ure 1C, middle panel). Altogether, pure blastema WT Xnsare solely composed of NCAM1+SIX2+ cells, indicating
their primitive renal nature.
The Tumorigenic Potential of Pure BlastemaWTXns Is
Maintained Solely by the ALDH1+ Cell Population
Establishment of pure blastema Xns afforded the opportu-
nity to sort single ALDH1+ cells and determine whether
they exclusively function as CSCs and investigate their
lineage relationship to all other non-CSC blastema cells.
Localization of ALDH1 was initially determined in the
pure blastema model using IHC. Scattered ALDH1+ cells
were localized within the SIX2+ blastema (Figure 1C, right
panel; Figure S1B). Late Xn cells were then sorted according
to ALDH1 activity with high efficiency as shown via quan-
titative real-time PCR analysis (Figure S2A). Limiting-dilu-
tion xenotransplantation experiments revealed that only
ALDH1+ cells have the capacity to form tumors. Moreover,
as few as 200 cells were sufficient to form new WT Xns,
demonstrating the high tumorigenic potential of ALDH1+
cells (Figure 2A). Thus, as in early passages, in these late
passages, the ability to sustain and propagate the tumor is
maintained solely by ALDH1+ cells. Because resistance to
conventional radio- and chemotherapies is a trait of CSCs
in several malignancies (Bonnet and Dick, 1997; Reya
et al., 2001), we examined the in vitro response of
ALDH1+ WT cells to radiation. Following exposure of WT
Xn cells to ionizing radiation, an increase in ALDH1+
cells was noted (Figure 2B). Moreover, the percentage of
ALDH1+ cells correlated with exposure time and radiation
intensity in a dose-dependent manner (Figure 2C). Hence,
ALDH1+ WT CSCs demonstrate increased resistance to
conventional radiation treatment. Taken together, these
results indicate that ALDH1+ cells function as CSCs in
pure blastema Xns.
Analysis of WT CSC Fraction in Relation with
Embryonic Renal Differentiation Reveals
Developmental Heterogeneity in WT Blastema
Wehave previously shown that earlyWT Xns derived from
sorted NCAM1+ALDH1+ CSCs harbor a higher percentage
of ALDH1+ cells compared to tumors derived fromunsorted
cells (USs). In order to determine whether this trait is
retained in pure blastema WT Xns, we compared ALDH1
expression between late Xns derived from ALDH1+ sorted
cells and those derived from USs. Fluorescence-activated
cell sorting (FACS) analysis revealed that the former are en-
riched for ALDH1+ CSCs (21.2% versus 5.6%, respectively)
(Figures 3A, 3B, and S2B). Next, we performed global gene
expression and proteomic analyses on these CSC-enriched
(CSC-En) tumors in comparison with tumors derived from
USs from the same tumor source (Figures 3C, 3D, and Table
S1, respectively). We performed a microarray gene expres-
sion analysis comparing three samples: (1) human fetalStem Cell Reports j Vol. 3 j 24–33 j July 8, 2014 j ª2014 The Authors 25
Figure 1. Generation of Pure Blastema
WT Xns
(A) Serial propagation of human WT Xn in
NOD-SCID mice results in enrichment of
NCAM1+ WT blastema, at the expense of
differentiated structures.
(B) IHC staining of pWTs, early-passage Xns,
and late-passage Xns for NCAM1. Early pas-
sages show great histological similarity to
their parent tumor (B, blastema; IT, imma-
ture tubule; St, stroma; GB, glomeruloid
bodies) with minor enrichment for the
blastema (NCAM1+) compartment. However,
late-passage Xns are composed of 100%
NCAM1+ blastemal cells and are devoid of
differentiated elements. Scale bars, 2 mm
(top) and 200 mm (bottom).
(C) IHC staining of pure blastema WT Xns for
NCAM1 (right), SIX2 (middle), and ALDH1
(left). All the tumor cells are NCAM1+SIX2+,
whereas ALDH1+ cells are scattered within
these blastemal sheets. Scale bars, 200 mm.
See also Figure S1.
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we performed hierarchical clustering in order to char-
acterize the three sampleswith respect to the renal develop-
mental signature, as manifested by the expression of
several renal developmental genes (i.e., SIX2, SALL1,
OSR1, CITED1, and PAX2). The results demonstrated ge-
netic proximity between the twoXn samples, both express-
ing high levels of the aforementioned genes, compared to
hFK, confirming that the pure blastema Xns harbor pro-
perties of primitive renal tissue. Interestingly, when
comparing the two Xn samples, we found that CSC-En
Xns expressed lower levels of the renal developmental
genes (Figure 3C). We next carried out a quantitative real-26 Stem Cell Reports j Vol. 3 j 24–33 j July 8, 2014 j ª2014 The Authorstime PCR analysis comparing the two Xn samples. This
comparison validated the lower expression levels of the
renal developmental gene set in the CSC-En sample.
Importantly, CSC-En tumors showed higher expression of
stemness genes (i.e.,NANOG, BMI1, and EZH2), supporting
enrichment for WT CSCs (Figure 3D). In addition, pro-
teomic analysis supported the gene expression data,
demonstrating a relative epithelial phenotype (i.e., high
E-Cadherin) of the CSC-En tumors compared to US tumors
(Table S1). Concomitantly, CSC-En tumors show upregu-
lation of stemness-associated signaling pathways at the
protein level (e.g., nuclear factor-kB [NF-kB], Wnt, phos-
phatidylinositol 3-kinase [PI3K], and mammalian target
Figure 2. The Tumorigenic Potential of Pure Blastema WT Xns Is Maintained Solely by the ALDH1+ Cell Population
(A) Scheme shows that ALDH1+ WT cells retain their CSC phenotype in pure blastema Xns. Pure blastema Xns were sorted according to
ALDH1 activity. ALDH1+ and ALDH1 blastemal cells were then injected into mice. Only ALDH1+ cells were able to initiate tumors in all
dilutions applied, whereas ALDH1 cells failed to form tumors altogether. Following ALDH1+-derived tumor growth, sorting and injections
of ALDH1+ and ALDH1 cells were repeated with equivalent results, confirming that ALDH1+ cells maintain self-renewal capacity in pure
blastema Xns.
(B) Representative FACS analysis of untreated Xn cells in comparison to Xn cells treated with ionizing radiation at an intensity of 10 Gy
reveals enrichment of ALDH1+ population.
(legend continued on next page)
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Xns, enriched for ALDH1+ CSCs, demonstrate a more
epithelial phenotype than their US-derived counterparts,
while maintaining their stemness. We next determined
whether culture conditions of pure blastema Xn cells can
recapitulate in vivo findings. We employed low-attach-
ment conditions to grow CSC-En tumor spheres (Yano
et al., 2013) and interrogated their phenotype by compari-
son to adherent culture. Tumor spheres demonstrated high
ALDH1 expression, accompanied by high expression of
stemness genes (e.g., OCT4, NANOG, and Polycomb genes)
and skewing toward a more epithelial phenotype (i.e.,
lower SIX2,OSR1, CITED1, vimentin, and higher E-Cadherin
and EpCAM levels) (Figure 3E). Thus, altering culture condi-
tions to enrich for CSCs can result in a relative renal MET,
mirroring the in vivo state.
Global Gene Analysis Reveals that WT CSC Is Arrested
at a Renal Progenitor State, Committed to Epithelial
Differentiation
We next sought to characterize the molecular profile of the
ALDH1+CSCs. For this purpose, we performed amicroarray
gene expression analysis comparing three samples: (1)
sorted ALDH1+ cells, (2) sorted ALDH1 cells, and (3)
USs. This comparison revealed a unique gene expression
profile of the ALDH1+ CSCs that included high levels of
stemness genes (e.g., OCT4, SHH, LIN28A, and KLF4) and
relatively high levels of epithelial markers (e.g., Keratin
6c, Keratin 33a, Keratin 35, Claudin 7, Claudin 9, and
Claudin 13) alongside lower levels of mesenchymal
markers (e.g., vimentin, SNAI2, and MEST) (Figures 4A
and S3). Importantly, ALDH1+ cells demonstrated lower
levels of proliferation-related genes (e.g., PCNA, CCNB1,
and E2F1) compared to ALDH1 cells, suggesting a more
quiescent phenotype of this population (Figure 4A). In
order to validate the microarray data, quantitative real-
time PCR was performed on sorted ALDH1+ and ALDH1
cells derived from three different pure blastema WT Xn
sources. Characterization of these fractions demonstrated
that indeed ALDH1+ cells express lower levels of renal
developmental genes (Figure 4B). Moreover, higher
E-Cadherin and lower vimentin expression in ALDH1+
cells was noted in comparison to ALDH1 cells (Figure 4B).
In order to further evaluate the proliferative state of the
different factionswithin the pure blastemaWTXns,we car-
ried out flow cytometry cell-cycle analysis. In accordance
with the microarray data, the ALDH1+ fraction demon-
strated a higher percentage of cells in the G0/G1 phase(C) Summary of ionizing radiation effect on proliferation and ALDH1 ex
cell growth in a dose- and time-dependent manner. Right view shows
ALDH1+ CSC population in a dose- and time-dependent manner.
See also Figure S2.
28 Stem Cell Reports j Vol. 3 j 24–33 j July 8, 2014 j ª2014 The Authorscompared to USs (87.4% and 75.8%, respectively) (Fig-
ure S4). We next characterized ALDH1+ cells at the protein
level. We performed western blot analysis of renal MET
protein expression comparing four samples: (1) sorted
ALDH1+ Xn cells, (2) sorted ALDH1 Xn cells, (3) unsorted
Xn cells, and (4) primary WT (pWT). The results demon-
strated lower expression of SIX2 and higher expression of
E-Cadherin in ALDH1+ cells (Figure 4C). Interestingly,
pWT presented higher E-Cadherin levels and lower vimen-
tin and SIX2 levels compared to the Xn samples, empha-
sizing the mesenchymal, undifferentiated nature of the
blastema-pure tumors. In addition, immunofluorescence
(IF) staining of sorted ALDH1+ and ALDH1 WT Xn cells
for SIX2 and the epithelial markers E-Cadherin and cyto-
keratin (MNF 116) showed distinct staining patterns.
ALDH1+ cells presented significantly lower expression of
SIX2 (Figure 4D, left) and higher expression of epithelial
markers (Figure 4D, middle and right). Furthermore, in or-
der to demonstrate in vitro dedifferentiation capacity of
the ALDH1+ sorted fraction, cells were grown in culture
for 10 days. We observed the acquisition of amesenchymal
phenotype, as manifested by upregulation of vimentin
alongside downregulation of ALDH1 expression and the
epithelial markers E-Cadherin and EpCAM (Figure 4E).
Taken together, these results suggest that the WT CSCs
are not the least differentiated cells along the renal devel-
opmental MET axis but, rather, are arrested at a renal
progenitor state, committed to epithelial differentiation.
Thus, the WT CSCs are likely to dedifferentiate to propa-
gate WT blastema.DISCUSSION
Here, by comparing the WT CSCs with normal kidney
development, we discover two surprising fundamental
concepts. First, in terms of lineage hierarchy, the CSC
may not correspond to the earliest normal stem cell but
rather to a more differentiated progeny. Second, heteroge-
neity that mirrors renal stem cell differentiation is present
in the homogeneous-appearing WT blastema. Our earlier
observations (Pode-Shakked et al., 2013) disclosed high
similarity between WT CSCs and early renal stem cells.
These observations were based on propagation of trilineage
humanWT, in which the relationship of the CSC to tumor
bulk includes a comparison to blastema and also to mature
elements, placing the CSC as an undifferentiated renal cell
type. Our ability to examine pure blastema Xns enabledpression of Xn cells. Left view shows that ionizing radiation inhibits
that exposure of WT Xn cells to ionizing radiation enriches for the
(legend on next page)
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tumor bulk and the unraveling of the findings. Indeed,
the importance of the fine-tuning of our system is mani-
fested when comparing WT CSCs to parental tissues (i.e.,
hFK and pWT), disclosing a relatively undifferentiated
phenotype. This precise understanding of the relation
between the WT CSC and embryonic renal differentiation
affords insights from both oncologic and developmental
aspects. Multiple studies have highlighted the relationship
between CSCs and their differentiated progeny (Reya et al.,
2001), including WT CSCs, and their ability to generate
tubular structures and glomeruloid bodies (Little, 2005;
Pode-Shakked and Dekel, 2011; Pode-Shakked et al.,
2013). Nevertheless, the dedifferentiated progeny arising
from ALDH1+ WT CSCs, represented by the bulk of the
blastema and characterized by higher SIX2 and lower
E-Cadherin, illustrates mechanisms for WT and progres-
sion. Interestingly, partial reprogramming by pluripotent
stemness factors has been recently implicated in genera-
tion of a Wilms’-like tumor in vivo (Ohnishi et al., 2014).
Hypothetically, dedifferentiation of WT CSCs may also
account for the nonrenal mesenchymal elements observed
inWT. This notion is strengthened by the fact that develop-
mental lineages are already specified in the MM, and no
common nephron epithelial-stromal progenitor cell has
been documented (Brown et al., 2013; Kobayashi et al.,
2008; Pleniceanu et al., 2010; Self et al, 2006). Our work
may suggest a revision to the concept that the earliest trans-
formed renal stem cell capable of giving rise to differenti-
ated progeny is the tumor-initiating cell. Alternatively,
the WT cell of origin and WT CSCs responsible for tumor
propagation may not be the same cell. Resolution of this
matter utilizing a transgenic animal model of WT genera-
tion that employs specific CRE drivers of renal stem cells
(e.g., SIX2) might be complicated becauseWTCSCs expressFigure 3. Analysis of WT CSC Fraction in Relation with Renal MET
(A) Scheme presents WT Xns derived from ALDH1+ sorted cells (botto
blastema WT Xns derived from USs (top).
(B) Representative FACS analyses of WT Xns derived from either unsorte
ALDH1+ WT CSCs in the latter.
(C) Gene heatmap of pure blastema CSC-En tumors in comparison to US
to an even greater extent, the Xn derived from USs are enriched for th
(D) Validation via quantitative real-time PCR of renal developmental
stemness genes (i.e., NANOG, BMI1, and EZH2) (right) in unsorted and
unsorted-derived pure blastema WT Xn cells were used to normalize (th
respect to them. Results are presented as the mean ± SEM of five sepa
(E) Unsorted Xn cells were grown in two different culture conditions
(top), and sphere-forming cells, grown in low-attachment conditio
accompanied by high levels of stemness genes (i.e., OCT4, NANOG, TOP
of SIX2, OSR1, CITED1, and vimentin and higher levels of E-Cadherin
(therefore equaling one [1]), and other values were calculated with r
separate experiments. *p < 0.05; **p < 0.01.
See also Figure S2 and Tables S1 and S2.
30 Stem Cell Reports j Vol. 3 j 24–33 j July 8, 2014 j ª2014 The Authorssome levels of SIX2 and WT1. Finally, from the develop-
mental aspect, it remains to be determined how NCAM1+
human nephron progenitors isolated from the hFK and
representing more committed epithelial progenitors than
uninduced MM (Harari-Steinberg et al., 2013) are relevant
for WT once transformed.
From a more practical aspect, the unequivocal limiting-
dilution xenotransplantation data, illustrating ALDH1+
WT CSCs as critical for continued propagation of WT
blastema Xns, highlight the WT CSC as a therapeutic
target.We previously suggested anti-NCAM1-targeted ther-
apy as a useful means for WT eradication (Pode-Shakked
et al., 2013). Clearly, the NCAM1 expression domain
exceeds that of the WT CSC. In this regard, our genomic
and proteomic data disclose several specific pathways
(e.g., NF-kB, Wnt, PI3K, and mTOR) previously implicated
in stemness acquisition (Armstrong et al., 2006; Huang
et al., 2012; Katoh and Katoh, 2007; Shostak and Chariot,
2011) as highly operative in WT CSCs. Thus, global anal-
ysis not only sheds light on the WT CSC as possessing
enhanced stemness alongside a more differentiated renal
phenotype but also pinpoints interventions such as
mTOR and epidermal growth factor receptor inhibition
that may prove beneficial in WT CSC eradication.EXPERIMENTAL PROCEDURES
Detailed Experimental Procedures are provided in the Supple-
mental Experimental Procedures.pWT Samples
pWT samples were obtained from patients with WTwithin 1 hr of
surgery from both Sheba Medical Center and Hadassah-EinKerem
hospital. All studies were approved by the local ethics committee,Axis Reveals Developmental Heterogeneity in WT Blastema
m) that show enrichment in ALDH1+ CSCs in comparison with pure
d WT cells (top) or ALDH1+ WT cells (bottom) showing enrichment in
-derived Xn and hFK. This analysis revealed that the CSC-En Xn and,
e earliest renal developmental gene set in comparison to the hFK.
genes (i.e., WT1, SIX2, SALL1, OSR1, CITED1, and PAX2) (left) and
CSC-En Xns. For quantitative real-time PCR analyses, the values for
erefore equaling one [1]), and all other values were calculated with
rate experiments obtained from three different patients. *p < 0.05.
(images by light microscopy are shown on the left): adherent cells
ns (bottom). The spheres demonstrated high ALDH1 expression
2A, and EZH2) along with a more epithelial phenotype (lower levels
and EpCAM). The values for adherent cells were used to normalize
espect to them. Results are presented as the mean ± SEM of three
(legend on next page)
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patients involved according to the Declaration of Helsinki.
In Vivo Xn Formation
The animal experiments were performed in accordance with the
Guidelines for Animal Experiments of Sheba Medical Center.
Initial WT xenografting to 5- to 8-week-old, female, nonobese
diabetic severe combined immunodeficiency (NOD-SCID) mice
was performed as previously described (Dekel et al., 2006). Late-
passage Xns were formed by serial injections of approximately
106 dissociated cells from freshly retrieved WT Xns. Cells were in-
jected in 100 ml 1:1 serum-free medium/Matrigel (BD Biosciences).
See also Supplemental Experimental Procedures.
Statistical Analysis
Results are expressedas themean± SEM,unlessotherwise indicated.
Statistical differences in gene expression between WT cell popula-
tions were evaluated using the nonparametric, one-sided sign test.
Statistical differences between additional data groups were deter-
mined with Student’s t test. For all statistical analyses, the level of
significance was set as p < 0.05, unless otherwise indicated.
ACCESSION NUMBERS
The GEO accession number for the chromatin immunoprecipita-
tion array data reported in this paper is GSE57269.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and three tables and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2014.05.013.Figure 4. Global Analysis Reveals a Distinct Profile of CSCs Congr
Molecular profile analyses of WT ALDH1+ CSCs.
(A) Microarray gene expression analysis of WT CSCs. A table is shown of
cells. ALDH1+ CSCs demonstrate low levels of proliferation-related gene
genes (e.g., SIX2, OSR1, and CITED1), high levels of stemness genes (e
markers (E-Cadherin, Keratin 6c, Keratin 33a, Keratin 35, Claudin 7, Cl
(vimentin, SNAI2, and MEST).
(B) Quantitative real-time PCR demonstrating significantly reduced le
PAX2) along with elevation of E-Cadherin (E-CAD) and decreased vime
normalize (therefore equaling one [1]), and all other values were calcu
of five separate experiments obtained from three different patients.
(C) Western blot analysis of renal MET protein expression in four samp
This analysis demonstrated lower expression of SIX2 and higher expres
In addition, pWT cells present higher levels of E-Cadherin and low
emphasizing the mesenchymal nature of the blastema-pure tissues.
(D) IF staining of sorted ALDH1+ and ALDH1 WT Xn cells for SIX2 (le
cytokeratin (right panel). A distinct staining pattern showing higher p
SIX2 in ALDH1+ in comparison with ALDH1 cells can be seen. Scale
(E) ALDH1+ sorted cells were grown for 10 days in culture. Gene expre
(ALDH+ 10 days) revealed significant downregulation of ALDH1 express
the epithelial markers E-Cadherin and EpCAM (right), demonstrating pla
normalize (therefore equaling one [1]), and all other values were calcu
of three separate experiments. *p < 0.05; **p < 0.01.
See also Figures S3 and S4 and Table S3.
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